loader
Please Wait
Applying Filters...

Suanfarma Suanfarma

X

List of All Manufacturers & Suppliers of Tapentadol Hydrochloride Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Alfred E Tiefenbacher GmbH (20)

02 Pharmathen SA (5)

03 Actavis Inc (7)

04 Alkem Laboratories (3)

05 Biodeal Pharmaceuticals (1)

06 CHEMO (6)

07 Collegium Pharmaceutical (9)

08 ENDO VENTURES LTD. (8)

09 Grunenthal (6)

10 Grünenthal GmbH (12)

11 Grünenthal GmbH, (11)

12 Grünenthal Pharma AG (19)

13 HUMANWELL PHARMACEUTICAL US INC (2)

14 Health Biotech (2)

15 Johnson & Johnson Innovative Medicine (5)

16 Orchid Pharma (9)

17 Precise Group (7)

18 RHODES PHARMACEUTICALS LP (2)

19 ROXANE (3)

20 Seqirus (5)

21 Vega Biotech Pvt. Ltd. (1)

22 West-ward Pharmaceutical Corp (4)

23 Blank (24)

filter

01 Antic-calc Tablet, Film Coated (1)

02 Depottablett (10)

03 ER TABLET (7)

04 ER Tablet (4)

05 Extended-Release Tablet (12)

06 FILM COATED PILL (4)

07 Film Coated Tablet (6)

08 Film Tablet (6)

09 Nasal Spray (1)

10 ORAL SOLUTION (2)

11 PROLONGED-RELEASE TABLET (6)

12 Prolonged Release Tablet (5)

13 SOLUTION;ORAL (2)

14 SR Tablet (12)

15 SRT (3)

16 Solution (5)

17 TAB (2)

18 TABLET (3)

19 TABLET (EXTENDED-RELEASE) (5)

20 TABLET (IMMEDIATE RELEASE) (3)

21 TABLET, EXTENDED RELEASE;ORAL (14)

22 TABLET; ORAL (2)

23 TABLET;ORAL (12)

24 Tablet (23)

25 Tapentadolo 100Mg 30 Joined' Oral Use Rp (1)

26 Tapentadolo 150Mg 30 Joined' Oral Use Rp (1)

27 Tapentadolo 200Mg 30 Joined' Oral Use Rp (1)

28 Tapentadolo 250Mg 30 Joined' Oral Use Rp (1)

29 Tapentadolo 25Mg 40 Combined Oral Use Rp (1)

30 Tapentadolo 50Mg 30 Joined' Oral Use Rp (1)

31 XR Tablet (10)

32 Blank (5)

filter

01 DISCN (1)

02 EU Dossier Readiness-Q1 2020 (2)

03 EU Dossier Readiness-Q3 2019 (4)

04 Generic (8)

05 Generic EU CTD (9)

06 Narcotic (CDSA I) (8)

07 Originator (5)

08 RX (8)

09 Status- Early Development (14)

10 Under registration in India (12)

11 Blank (100)

filter

01 60 Palexia Retard 100Mg Extended Release Tablets (1)

02 60 Palexia Retard 150Mg Extended Release Tablets (1)

03 60 Palexia Retard 200Mg Extended Release Tablets (1)

04 60 Palexia Retard 250Mg Extended Release Tablets (1)

05 60 Palexia Retard 25Mg Extended Release Tablets (1)

06 60 Palexia Retard 50Mg Extended Release Tablets (1)

07 60 Yantil Retard 100Mg Extended Release Tablets (1)

08 60 Yantil Retard 150Mg Extended Release Tablets (1)

09 60 Yantil Retard 200Mg Extended Release Tablets (1)

10 60 Yantil Retard 250Mg Extended Release Tablets (1)

11 60 Yantil Retard 25Mg Extended Release Tablets (1)

12 60 Yantil Retard 50Mg Extended Release Tablets (1)

13 NUCYNTA (4)

14 NUCYNTA ER (5)

15 NUCYNTA EXTENDED-RELEASE (5)

16 NUCYNTA IR (3)

17 Palexia (13)

18 Palexia 100 mg (1)

19 Palexia 50 mg (1)

20 Palexia Depot (16)

21 Palexia SR (5)

22 Palexia SR 100 mg (1)

23 Palexia SR 200 mg (1)

24 Palexia SR 50 mg (1)

25 TAPENTADOL (16)

26 TAPENTADOL HYDROCHLORIDE (5)

27 Tapencet ER (1)

28 Tapentadol Hydrochloride (1)

29 Blank (80)

filter

01 Australia (5)

02 Canada (8)

03 Germany (20)

04 Greece (5)

05 India (32)

06 Italy (6)

07 Norway (11)

08 South Africa (5)

09 Spain (18)

10 Sweden (12)

11 Switzerland (19)

12 USA (30)

URL Supplier Web Content
Film Coated Tablet
50MG
EU Dossier Readiness-Q1 2020
Germany
URL Supplier Web Content
Film Coated Tablet
75MG
EU Dossier Readiness-Q3 2019
Germany
URL Supplier Web Content
Film Coated Tablet
100MG
EU Dossier Readiness-Q3 2019
Germany
URL Supplier Web Content
XR Tablet
50MG
Status- Early Development
Germany
URL Supplier Web Content
XR Tablet
100MG
Status- Early Development
Germany
URL Supplier Web Content
XR Tablet
150MG
Status- Early Development
Germany
URL Supplier Web Content
XR Tablet
200MG
Status- Early Development
Germany
URL Supplier Web Content
XR Tablet
250MG
Status- Early Development
Germany
URL Supplier Web Content
Solution
4MG/ML
Status- Early Development
Germany
URL Supplier Web Content
Solution
20MG/ML
Status- Early Development
Germany
URL Supplier Web Content
Film Coated Tablet
50MG
EU Dossier Readiness-Q1 2020
Germany
URL Supplier Web Content
Film Coated Tablet
75MG
EU Dossier Readiness-Q3 2019
Germany
URL Supplier Web Content
Film Coated Tablet
100MG
EU Dossier Readiness-Q3 2019
Germany
URL Supplier Web Content
XR Tablet
50MG
Status- Early Development
Germany
URL Supplier Web Content
XR Tablet
100MG
Status- Early Development
Germany
URL Supplier Web Content
XR Tablet
150MG
Status- Early Development
Germany
URL Supplier Web Content
XR Tablet
200MG
Status- Early Development
Germany
URL Supplier Web Content
XR Tablet
250MG
Status- Early Development
Germany
URL Supplier Web Content
Solution
4MG/ML
Status- Early Development
Germany
Post Enquiry
POST ENQUIRY